Skip to Main Content

Latest News

  • Caroline Johnson Receives American Cancer Society Research Scholar Grant

    Caroline Johnson, Ph.D., Assistant Professor of Epidemiology in the Department of Environmental Health Sciences at Yale School of Public Health and a member of Yale Cancer Center’s Cancer Microbiology Research Program, has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society (ACS).

    Read more
  • YSPH Convenes Experts to Examine Alcohol’s Role in Cancer

    Chronic alcohol abuse is considered to be an important risk factor for disease worldwide. In addition, alcohol and its metabolite, acetaldehyde, are recognized as carcinogens that contribute to four percent of cancer deaths. Although scientific studies began to show this association over 100 years ago, the role of alcohol in chronic diseases such as cancer is still not well understood by the public and medical professionals. The 4th International Conference on Alcohol and Cancer was organized by Vasilis Vasiliou, PhD, the Susan Dwight Bliss Professor of Epidemiology, sponsored by the Department of Environmental Health Sciences of the Yale School of Public Health, and supported by an R13 grant from the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The conference, held in Newport, R.I., brought together 75 international scholars with special interest in alcohol and/or cancer.

    Read more
  • Collaborating Against Obesity + Cancer

    In the past decade, the list of cancers clearly associated with obesity or excessive weight has been growing: breast, kidney, uterine, pancreatic, colorectal, and esophageal cancers all are linked to obesity.

    Read more
  • Metabolomics and the Exposotype: Linking genes and environment to human health

    Through the combination of genomics and metabolomics research, scientists are getting closer to understanding the impact of environmental exposure and lifestyle on disease onset. This recently designated "exposotype" (which takes into account genomic and metabolic data) is a new tool researchers can potentially use to refine and revolutionize current thinking about precision medicine and risk assessment.

    Source: BMC Blog Network
    Read more